Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Now a Good Time to Buy Biogen Stock?


Biogen (NASDAQ: BIIB) faces continued challenges for several of its current products. However, the company also now has Alzheimer's disease drug Aduhelm, which could be a huge commercial success. In this Motley Fool Live video, recorded on July 19, 2021, healthcare and cannabis bureau chief Corinne Cardina and Motley Fool contributor Keith Speights answer a viewer's question about whether now is a good time to buy Biogen stock.

Continue reading


Source Fool.com

Like: 0
Share

Comments